APO Research, Inc.

APO RESEARCH · REPORT

Alvimopan

Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.

Product & engineering

Understand the product.

Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.

Selected research

Industry Growth & Trends

Global Alvimopan Industry Growth and Trends Forecast to 2032

Market perspective

Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.

Alvimopan (CAS 156053-89-3) is widely used in Pharmaceutical and Other field. The most proportion of Alvimopan (CAS 156053-89-3) is used in Pharmaceutical, and the proportion in 2019 is 88.64%. Market competition is intense. Merck is the leaders of the industry, and they hold key technologies and patents, with high-end customers.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Alvimopan market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Alvimopan market size, estimates, and forecasts are presented in terms of sales volume (KG) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Alvimopan market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Alvimopan.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Alvimopan market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Alvimopan Market by Company

Merck

Teva Pharmaceutical Industries Ltd

MSN Life Sciences Private Ltd

Alvimopan Segment by Type

Pharmaceutical Grade

Others

Alvimopan Segment by Application

Pharmaceutical

Other

Alvimopan Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alvimopan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alvimopan and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alvimopan.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alvimopan manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Alvimopan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Pharmaceutical Grade Table 2. Major Company of Others Table 3. Global Alvimopan Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Alvimopan Sales by Type (2021-2026) & (KG) Table 5. Global Alvimopan Sales Market Share in Volume by Type (2021-2026) Table 6. Global Alvimopan Sales by Type (2021-2026) & (US$ Million) Table 7. Global Alvimopan Sales Market Share in Value by Type (2021-2026) Table 8. Global Alvimopan Price by Type (2021-2026) & (US$/g) Table 9. Global Alvimopan Sales by Type (2027-2032) & (KG) Table 10. Global Alvimopan Sales Market Share in Volume by Type (2027-2032) Table 11. Global Alvimopan Sales by Type (2027-2032) & (US$ Million) Table 12. Global Alvimopan Sales Market Share in Value by Type (2027-2032) Table 13. Global Alvimopan Price by Type (2027-2032) & (US$/g) Table 14. North America Alvimopan Sales by Type (2021-2026) & (KG) Table 15. North America Alvimopan Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Alvimopan Sales by Type (2021-2026) & (KG) Table 17. Europe Alvimopan Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Alvimopan Sales by Type (2021-2026) & (KG) Table 19. Asia-Pacific Alvimopan Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Alvimopan Sales by Type (2021-2026) & (KG) Table 21. Latin America Alvimopan Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Alvimopan Sales by Type (2021-2026) & (KG) Table 23. Middle East and Africa Alvimopan Sales by Type (2021-2026) & (US$ Million) Table 24. Alvimopan Industry Trends Table 25. Alvimopan Industry Drivers Table 26. Alvimopan Industry Opportunities and Challenges Table 27. Alvimopan Industry Restraints Table 28. Global Alvimopan Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Alvimopan Revenue Market Share by Company (2021-2026) Table 30. Global Alvimopan Sales by Company (2021-2026) & (KG) Table 31. Global Alvimopan Sales Share by Company (2021-2026) Table 32. Global Alvimopan Market Price by Company (2021-2026) & (US$/g) Table 33. Global Alvimopan Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Alvimopan Major Company Production Sites and Headquarters Table 35. Global Alvimopan Company, Product Type & Application Table 36. Global Alvimopan Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Alvimopan by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Alvimopan Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Alvimopan Sales by Region (2021-2026) & (KG) Table 41. Global Alvimopan Sales Market Share in Volume by Region (2021-2026) Table 42. Global Alvimopan Sales by Region (2021-2026) & (US$ Million) Table 43. Global Alvimopan Sales Market Share in Value by Region (2021-2026) Table 44. Global Alvimopan Sales (KG), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 45. Global Alvimopan Sales by Region (2027-2032) & (KG) Table 46. Global Alvimopan Sales Market Share in Volume by Region (2027-2032) Table 47. Global Alvimopan Sales by Region (2027-2032) & (US$ Million) Table 48. Global Alvimopan Sales Market Share in Value by Region (2027-2032) Table 49. Global Alvimopan Sales (KG), Value (US$ Million), Price (US$/g) and Gross Margin (2027-2032) Table 50. Global Alvimopan Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Alvimopan Sales by Application (2021-2026) & (KG) Table 52. Global Alvimopan Sales Market Share in Volume by Application (2021-2026) Table 53. Global Alvimopan Sales by Application (2021-2026) & (US$ Million) Table 54. Global Alvimopan Sales Market Share in Value by Application (2021-2026) Table 55. Global Alvimopan Price by Application (2021-2026) & (US$/g) Table 56. Global Alvimopan Sales by Application (2027-2032) & (KG) Table 57. Global Alvimopan Sales Market Share in Volume by Application (2027-2032) Table 58. Global Alvimopan Sales by Application (2027-2032) & (US$ Million) Table 59. Global Alvimopan Sales Market Share in Value by Application (2027-2032) Table 60. Global Alvimopan Price by Application (2027-2032) & (US$/g) Table 61. North America Alvimopan Sales by Application (2021-2026) & (KG) Table 62. North America Alvimopan Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Alvimopan Sales by Application (2021-2026) & (KG) Table 64. Europe Alvimopan Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Alvimopan Sales by Application (2021-2026) & (KG) Table 66. Asia-Pacific Alvimopan Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Alvimopan Sales by Application (2021-2026) & (KG) Table 68. Latin America Alvimopan Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Alvimopan Sales by Application (2021-2026) & (KG) Table 70. Middle East and Africa Alvimopan Sales by Application (2021-2026) & (US$ Million) Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck Alvimopan Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 74. Merck Alvimopan Product Portfolio Table 75. Merck Recent Development Table 76. Teva Pharmaceutical Industries Ltd Company Information Table 77. Teva Pharmaceutical Industries Ltd Business Overview Table 78. Teva Pharmaceutical Industries Ltd Alvimopan Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 79. Teva Pharmaceutical Industries Ltd Alvimopan Product Portfolio Table 80. Teva Pharmaceutical Industries Ltd Recent Development Table 81. MSN Life Sciences Private Ltd Company Information Table 82. MSN Life Sciences Private Ltd Business Overview Table 83. MSN Life Sciences Private Ltd Alvimopan Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 84. MSN Life Sciences Private Ltd Alvimopan Product Portfolio Table 85. MSN Life Sciences Private Ltd Recent Development Table 86. North America Alvimopan Market Size Growth Rate (CAGR) by Country (KG): 2021 VS 2025 VS 2032 Table 87. North America Alvimopan Sales by Country (2021-2026) & (KG) Table 88. North America Alvimopan Sales Market Share by Country (2021-2026) Table 89. North America Alvimopan Sales Forecast by Country (2027-2032) & (KG) Table 90. North America Alvimopan Sales Market Share Forecast by Country (2027-2032) Table 91. North America Alvimopan Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America Alvimopan Market Size by Country (2021-2026) & (US$ Million) Table 93. North America Alvimopan Market Share by Country (2021-2026) Table 94. North America Alvimopan Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America Alvimopan Market Share Forecast by Country (2027-2032) Table 96. Europe Alvimopan Market Size Growth Rate (CAGR) by Country (KG): 2021 VS 2025 VS 2032 Table 97. Europe Alvimopan Sales by Country (2021-2026) & (KG) Table 98. Europe Alvimopan Sales Market Share by Country (2021-2026) Table 99. Europe Alvimopan Sales Forecast by Country (2027-2032) & (KG) Table 100. Europe Alvimopan Sales Market Share Forecast by Country (2027-2032) Table 101. Europe Alvimopan Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe Alvimopan Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe Alvimopan Market Share by Country (2021-2026) Table 104. Europe Alvimopan Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe Alvimopan Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Alvimopan Market Size Growth Rate (CAGR) by Country (KG): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Alvimopan Sales by Country (2021-2026) & (KG) Table 108. Asia-Pacific Alvimopan Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific Alvimopan Sales Forecast by Country (2027-2032) & (KG) Table 110. Asia-Pacific Alvimopan Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Alvimopan Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Alvimopan Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific Alvimopan Market Share by Country (2021-2026) Table 114. Asia-Pacific Alvimopan Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific Alvimopan Market Share Forecast by Country (2027-2032) Table 116. Latin America Alvimopan Market Size Growth Rate (CAGR) by Country (KG): 2021 VS 2025 VS 2032 Table 117. Latin America Alvimopan Sales by Country (2021-2026) & (KG) Table 118. Latin America Alvimopan Sales Market Share by Country (2021-2026) Table 119. Latin America Alvimopan Sales Forecast by Country (2027-2032) & (KG) Table 120. Latin America Alvimopan Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America Alvimopan Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America Alvimopan Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America Alvimopan Market Share by Country (2021-2026) Table 124. Latin America Alvimopan Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America Alvimopan Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Alvimopan Market Size Growth Rate (CAGR) by Country (KG): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Alvimopan Sales by Country (2021-2026) & (KG) Table 128. Middle East and Africa Alvimopan Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa Alvimopan Sales Forecast by Country (2027-2032) & (KG) Table 130. Middle East and Africa Alvimopan Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Alvimopan Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Alvimopan Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa Alvimopan Market Share by Country (2021-2026) Table 134. Middle East and Africa Alvimopan Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa Alvimopan Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Alvimopan Distributors List Table 139. Alvimopan Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Alvimopan Image Figure 2. Global Alvimopan Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alvimopan Market Size (2021-2032) & (US$ Million) Figure 4. Global Alvimopan Sales (2021-2032) & (KG) Figure 5. Pharmaceutical Grade Image Figure 6. Global Pharmaceutical Grade Sales YoY Growth (2021-2032) & (KG) Figure 7. Others Image Figure 8. Global Others Sales YoY Growth (2021-2032) & (KG) Figure 9. Global Alvimopan Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Alvimopan Market Share by Type 2025 VS 2032 Figure 11. North America Alvimopan Sales Market Share in Volume by Type in 2025 Figure 12. North America Alvimopan Sales Market Share in Value by Type in 2025 Figure 13. Europe Alvimopan Sales Market Share in Volume by Type in 2025 Figure 14. Europe Alvimopan Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Alvimopan Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Alvimopan Sales Market Share in Value by Type in 2025 Figure 17. Latin America Alvimopan Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Alvimopan Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Alvimopan Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Alvimopan Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Alvimopan Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Pharmaceutical Image Figure 24. Global Pharmaceutical Sales YoY Growth (2021-2032) & (KG) Figure 25. Other Image Figure 26. Global Other Sales YoY Growth (2021-2032) & (KG) Figure 27. Global Alvimopan Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Alvimopan Market Share by Application 2025 VS 2032 Figure 29. North America Alvimopan Sales Market Share in Volume by Application in 2025 Figure 30. North America Alvimopan Sales Market Share in Value by Application in 2025 Figure 31. Europe Alvimopan Sales Market Share in Volume by Application in 2025 Figure 32. Europe Alvimopan Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Alvimopan Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Alvimopan Sales Market Share in Value by Application in 2025 Figure 35. Latin America Alvimopan Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Alvimopan Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Alvimopan Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Alvimopan Sales Market Share in Value by Application in 2025 Figure 39. North America Alvimopan Sales by Country: 2021 VS 2025 VS 2032 (KG) Figure 40. North America Alvimopan Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Alvimopan Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Alvimopan Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Alvimopan Sales by Country: 2021 VS 2025 VS 2032 (KG) Figure 44. Europe Alvimopan Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Alvimopan Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Alvimopan Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Alvimopan Sales by Country: 2021 VS 2025 VS 2032 (KG) Figure 48. Asia-Pacific Alvimopan Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Alvimopan Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Alvimopan Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Alvimopan Sales by Country: 2021 VS 2025 VS 2032 (KG) Figure 52. Latin America Alvimopan Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Alvimopan Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Alvimopan Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Alvimopan Sales by Country: 2021 VS 2025 VS 2032 (KG) Figure 56. Middle East and Africa Alvimopan Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Alvimopan Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Alvimopan Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Alvimopan Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Alvimopan Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmaceutical Grade
  • Others
Applications
  • Pharmaceutical
  • Other
Companies covered
  • Merck
  • Teva Pharmaceutical Industries Ltd
  • MSN Life Sciences Private Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Alvimopan Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Alvimopan Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Alvimopan Market by Type
  6. 1.3.1 Pharmaceutical Grade
  7. 1.3.2 Others
  8. 1.4 Global Alvimopan Market Size by Type
  9. 1.4.1 Global Alvimopan Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Alvimopan Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Alvimopan Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Alvimopan Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Alvimopan Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Alvimopan Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Alvimopan Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Alvimopan Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Alvimopan Industry Trends
  2. 2.2 Alvimopan Industry Drivers
  3. 2.3 Alvimopan Industry Opportunities and Challenges
  4. 2.4 Alvimopan Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Alvimopan Revenue (2021-2026)
  2. 3.2 Global Top Players by Alvimopan Sales (2021-2026)
  3. 3.3 Global Top Players by Alvimopan Price (2021-2026)
  4. 3.4 Global Alvimopan Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Alvimopan Major Company Production Sites & Headquarters
  6. 3.6 Global Alvimopan Company, Product Type & Application
  7. 3.7 Global Alvimopan Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Alvimopan Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Alvimopan Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Alvimopan Tier 1, Tier 2, and Tier 3
4 Alvimopan Regional Status and Outlook
  1. 4.1 Global Alvimopan Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Alvimopan Historic Market Size by Region
  3. 4.2.1 Global Alvimopan Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Alvimopan Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Alvimopan Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Alvimopan Forecasted Market Size by Region
  7. 4.3.1 Global Alvimopan Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Alvimopan Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Alvimopan Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Alvimopan by Application
  1. 5.1 Alvimopan Market by Application
  2. 5.1.1 Pharmaceutical
  3. 5.1.2 Other
  4. 5.2 Global Alvimopan Market Size by Application
  5. 5.2.1 Global Alvimopan Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Alvimopan Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Alvimopan Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Alvimopan Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Alvimopan Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Alvimopan Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Alvimopan Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Alvimopan Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Alvimopan Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Alvimopan Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 Teva Pharmaceutical Industries Ltd
  8. 6.2.1 Teva Pharmaceutical Industries Ltd Company Information
  9. 6.2.2 Teva Pharmaceutical Industries Ltd Business Overview
  10. 6.2.3 Teva Pharmaceutical Industries Ltd Alvimopan Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Pharmaceutical Industries Ltd Alvimopan Product Portfolio
  12. 6.2.5 Teva Pharmaceutical Industries Ltd Recent Developments
  13. 6.3 MSN Life Sciences Private Ltd
  14. 6.3.1 MSN Life Sciences Private Ltd Company Information
  15. 6.3.2 MSN Life Sciences Private Ltd Business Overview
  16. 6.3.3 MSN Life Sciences Private Ltd Alvimopan Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 MSN Life Sciences Private Ltd Alvimopan Product Portfolio
  18. 6.3.5 MSN Life Sciences Private Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Alvimopan Sales by Country
  2. 7.1.1 North America Alvimopan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Alvimopan Sales by Country (2021-2026)
  4. 7.1.3 North America Alvimopan Sales Forecast by Country (2027-2032)
  5. 7.2 North America Alvimopan Market Size by Country
  6. 7.2.1 North America Alvimopan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Alvimopan Market Size by Country (2021-2026)
  8. 7.2.3 North America Alvimopan Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Alvimopan Sales by Country
  2. 8.1.1 Europe Alvimopan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Alvimopan Sales by Country (2021-2026)
  4. 8.1.3 Europe Alvimopan Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Alvimopan Market Size by Country
  6. 8.2.1 Europe Alvimopan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Alvimopan Market Size by Country (2021-2026)
  8. 8.2.3 Europe Alvimopan Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Alvimopan Sales by Country
  2. 9.1.1 Asia-Pacific Alvimopan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Alvimopan Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Alvimopan Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Alvimopan Market Size by Country
  6. 9.2.1 Asia-Pacific Alvimopan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Alvimopan Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Alvimopan Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Alvimopan Sales by Country
  2. 10.1.1 South America Alvimopan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Alvimopan Sales by Country (2021-2026)
  4. 10.1.3 South America Alvimopan Sales Forecast by Country (2027-2032)
  5. 10.2 South America Alvimopan Market Size by Country
  6. 10.2.1 South America Alvimopan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Alvimopan Market Size by Country (2021-2026)
  8. 10.2.3 South America Alvimopan Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Alvimopan Sales by Country
  2. 11.1.1 Middle East and Africa Alvimopan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Alvimopan Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Alvimopan Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Alvimopan Market Size by Country
  6. 11.2.1 Middle East and Africa Alvimopan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Alvimopan Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Alvimopan Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Alvimopan Value Chain Analysis
  2. 12.1.1 Alvimopan Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Alvimopan Production Mode & Process
  7. 12.2 Alvimopan Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Alvimopan Distributors
  10. 12.2.3 Alvimopan Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.